{"id":"W2138973020","doi":"10.1136/bjophthalmol-2013-303232","title":"Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme","year":2013,"lang":"en","type":"article","venue":"British Journal of Ophthalmology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"ca_institutions":"Prism Eye Institute","funders":"Novartis Pharma; Allergan; Genentech; Pfizer; Karolinska Institutet; Sanofi; Heidelberg Engineering; Alimera Sciences; Rheinische Friedrich-Wilhelms-Universität Bonn; Université de Liège; GlaxoSmithKline","keywords":"Ranibizumab; Medicine; Macular degeneration; Incidence (geometry); Retrospective cohort study; Ophthalmology; Clinical trial; Adverse effect; Observational study; Population; Safety profile; Emergency medicine; Bevacizumab; Surgery; Internal medicine; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002254794,0.0001477574,0.001154414,0.0001903109,0.00004759882,0.00002616343,0.000226019,0.0001009437,0.0002297418],"category_scores_gemma":[0.003591825,0.0001137212,0.0007557754,0.0006687985,0.0003963358,0.0001445795,0.0000655214,0.0004894295,0.000005640271],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008649762,"about_ca_system_score_gemma":0.0001954433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001175134,"about_ca_topic_score_gemma":0.00001042333,"domain_scores_codex":[0.9963189,0.001091799,0.00163833,0.0002313672,0.0004723379,0.0002472627],"domain_scores_gemma":[0.9964418,0.0003282497,0.001673472,0.0003280334,0.001062243,0.0001661979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002337701,0.001747719,0.9533792,0.00004316836,0.00778292,0.02828668,0.0001701881,0.00004291033,0.00002854582,0.0001126014,0.0001074557,0.005960975],"study_design_scores_gemma":[0.005082384,0.002302276,0.9374061,0.0002324823,0.005053135,0.04888574,0.0006991192,0.00005153174,0.00001429513,0.000170298,0.00002435882,0.00007828431],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929721,0.001967384,0.00002487635,0.0005996083,0.0001063583,0.0004482392,0.00001748931,0.000004090141,0.003859806],"genre_scores_gemma":[0.9975038,0.0003407606,0.001835271,0.00003728907,0.00008326738,0.000004183684,0.00001562639,0.00002134627,0.0001585145],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02059907,"threshold_uncertainty_score":0.4637415,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02813690674955842,"score_gpt":0.3263384600215737,"score_spread":0.2982015532720153,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}